GEO Publications
Handout
NAR 2024 (latest)
NAR 2002 (original)
All publications
FAQ
MIAME
Email GEO
NCBI
>
GEO
>
Accession Display
Not logged in |
Login
GEO help:
Mouse over screen elements for information.
Scope:
Self
Platform
Samples
Series
Family
Format:
HTML
SOFT
MINiML
Amount:
Brief
Quick
GEO accession:
Sample GSM39494
Query DataSets for GSM39494
Status
Public on Apr 01, 2005
Title
pp186-1
Sample type
RNA
Source name
Staged C. elegans embryos
Organism
Caenorhabditis elegans
Extracted molecule
total RNA
Description
Mutant genotype pie-1(zu154); pal-1(RNAi) 186 minutes after the 4-cell embryonic stage at 22 degrees C
Sample_genotype: pp
Sample_time: 186
Submission date
Jan 24, 2005
Last update date
May 27, 2005
Contact name
Andrew Hill
E-mail(s)
andrew.hill@pfizer.com
Phone
617-674-6341
Organization name
Pfizer
Department
Research Business Technology
Street address
300 Technology Square
City
Cambridge
State/province
MA
ZIP/Postal code
02139
Country
USA
Platform ID
GPL200
Series (1)
GSE2180
C. elegans embryonic timecourse in wt and mutant embryos
Data table header descriptions
ID_REF
Affymetrix Qualifier
VALUE
RMA calulated using Bioconductor Affy package (http://www.bioconductor.org)
Data table
ID_REF
VALUE
171720_x_at
4.57331884900016
171721_x_at
6.92251519695912
171722_x_at
7.29416651635749
171723_x_at
3.28879524002358
171724_x_at
4.8856606528455
171725_x_at
4.16980455371781
171726_x_at
4.59395761260832
171727_x_at
2.51616923397941
171728_x_at
3.22369457849873
171729_x_at
7.62538405562809
171730_x_at
2.77716168051088
171731_x_at
8.09132983924394
171732_x_at
6.53379372979039
171733_x_at
7.79394511296388
171734_x_at
9.07837149573575
171735_x_at
3.27121984977315
171736_x_at
9.49962378343545
171737_x_at
9.28347242322224
171738_x_at
8.35828241586177
171739_x_at
3.25114280648139
Total number of rows:
22625
Table truncated, full table size
608 Kbytes
.
Supplementary file
Size
Download
File type/resource
GSM39494.CEL.gz
2.9 Mb
(ftp)
(http)
CEL
GSM39494.EXP.gz
332 b
(ftp)
(http)
EXP
|
NLM
|
NIH
|
GEO Help
|
Disclaimer
|
Accessibility
|
